Bayer

KOVALTRY

Manufacturer:

Bayer

Kovaltry HCPCS:

J7211

HCPCS Code Descriptor:

Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.

Category:

J Code

Kovaltry NDCs:

00026-3826-50, 00026-3821-25, 00026-3824-25, 00026-3828-50, 00026-3822-25

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Kovaltry CPT Codes:

Potential CPT administration codes for Kovaltry can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Kovaltry:

KOVALTRY is a Hematology drug manufactured by Bayer and administered via the Intravenous route of administration. The J Code: J7211 is aligned to the drug KOVALTRY.

ACCESS PRICING AND MORE BY REGISTERING

J7211 Added Date:

January 1, 2018

J7211 Effective Date:

January 1, 2018

J7211 Termination Date:

HCPCS Active

Kovaltry billing and coding information can be found through Bayer at the link below:
Kovaltry patient assistance information can be found through Bayer Patient Assistance at the URL: https://www.patientassistance.bayer.us/
KOVALTRY prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for KOVALTRY. Please check back in a few weeks.